SAN FRANCISCO — The executives and investors who flew here from all over the world for the drug industry’s annual confab this week brought with them presentations, elevator pitches — and, well, lots of bugs. Especially on their smartphones.
That’s why Weill Cornell Medicine researchers are conducting a study at the J.P. Morgan Healthcare Conference to analyze the DNA of the microbes on attendees’ cell phones. They want to see whether cities leave a distinct microbial footprint on their residents’ iPhones.
About the Author Reprints
